Skye Bioscience Inc (SKYE)

[cjarmstrong]

Old news. I posted that there was a previous deal that fell through, months ago, though I didn't know it was with Insys. They probably thought sublingual administration would have higher patient acceptance than a suppository which is certainly true. I also asked why he didn't sign a deal with Mallinckrodt since he already had a relationship with them. They probably weren't interested in a suppository.